Observational Study of Musculoskeletal Patients in an Emergency Department in France
Launched by HÔPITAL NOVO · May 31, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
There is a crisis in the emergency department (ED) in France, as their number of consultations have constantly increased over the past ten years . Musculoskeletal disorders (MSK) are the most common cause of consultations in ED, as an example there is an average of 30% of ED consultations being for traumatic issues . Moreover, 90% of all patients coming in ED in France have a favourable prognosis of evolution (no risk of seriousness). In this situation, one of the propositions to help to reduce the ED burden is to allow a direct access to physiotherapists. They are the recommended professio...
Gender
ALL
Eligibility criteria
- Inclusion Criteria :
- • Patients aged between 18 and 68
- • Patients admitted to emergency with a triage by the Reception and Referral Nurse of 0, 1 or 2
- * Patients who consulted for one of the following reasons:
- • Lower limb pain (T13.9) Lower limb trauma (M79.61) Upper limb pain (T11.9) Upper limb trauma (M79.60) Spinal pain (M54.9) Lumbar or flank pain (R10.3) Diffuse/unspecific pain (R52.9) Loss of sensitivity/paraesthesia
- • - Patients informed of the study and who did not object
- Exclusion Criteria :
- • Patients with another reason for consultation associated with the first
- • Patients under guardianship / curatorship and patients under safeguard of justice.
Trial Officials
Benoit ANCEL
Principal Investigator
Hôpital NOVO
About Hôpital Novo
Hôpital Novo is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies and rigorous scientific methodologies. With a strong emphasis on collaboration and ethical practices, Hôpital Novo partners with healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. Their commitment to patient safety, data integrity, and regulatory compliance ensures that all research initiatives are conducted to the highest standards, ultimately contributing to the development of new treatments and therapies that enhance healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pontoise, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0